Brigham and Women's Hospital: Alzheimer Disease trials
The registry lists 10 Alzheimer Disease studies with Brigham and Women's Hospital as lead sponsor. 3 are open to participants now and 3 have results posted.
Phase 1 4Phase 2 3No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's DiseaseNot yet recruitingNCT07795307Phase 1
- Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's DiseaseRecruitingNCT06489548Phase 2
- PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric DiseasesRecruitingNCT02649985Phase 1/2
- Deprescribing in Patients Living With Dementia With Caregiver and Provider NudgesCompletedNCT06347172Not applicableResults posted
- Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IVCompletedNCT01434667Not applicableResults posted
- REVEAL III: Risk Evaluation and Education for Alzheimer's DiseaseCompletedNCT00462917Not applicableResults posted
- Nasal Protollin in Early Symptomatic Alzheimer's DiseaseCompletedNCT07187141Phase 1
- Sirtuin-NAD Activator in Alzheimer's DiseaseCompletedNCT05040321Phase 1/2
- Network Modulation in Alzheimer's DiseaseCompletedNCT04045990Not applicable
- Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)CompletedNCT02959489Not applicable